Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.
Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Health Expect. 2024 Aug;27(4):e14143. doi: 10.1111/hex.14143.
Individuals with high risk for lung cancer may benefit from lung cancer screening, but there are associated risks as well as benefits. Shared decision-making (SDM) tools with personalized information may provide key support for patients. Understanding patient perspectives on educational tools to facilitate SDM for lung cancer screening may support tool development.
This study aimed to explore patient perspectives related to a SDM tool for lung cancer screening using a qualitative approach.
We elicited patient perspectives by showing a provider-facing SDM tool. Focus group interviews that ranged in duration from 1.5 to 2 h were conducted with 23 individuals with high risk for lung cancer. Data were interpreted inductively using thematic analysis to identify patients' thoughts on and desires for a patient-facing SDM tool.
The findings highlight that patients would like to have educational information related to lung cancer screening. We identified several key themes to be considered in the future development of patient-facing tools: barriers to acceptance, preference against screening and seeking empowerment. One further theme illustrated effects of patient-provider relationship as a limitation to meeting lung cancer screening information needs. Participants also noted several suggestions for the design of technology decision aids.
These findings suggest that patients desire additional information on lung cancer screening in advance of clinical visits. However, there are several issues that must be considered in the design and development of technology to meet the information needs of patients for lung cancer screening decisions.
Patients, service users, caregivers or members of the public were not involved in the study design, conduct, analysis or interpretation of the data. However, clinical experts in health communication provided detailed feedback on the study protocol, including the focus group approach. The study findings contribute to a better understanding of patient expectations for lung cancer screening decisions and may inform future development of tools for SDM.
高危肺癌患者可能受益于肺癌筛查,但也存在相关风险和获益。具有个性化信息的共享决策(SDM)工具可能为患者提供关键支持。了解患者对促进肺癌筛查 SDM 的教育工具的看法,可能有助于工具的开发。
本研究旨在通过定性方法探讨与肺癌筛查 SDM 工具相关的患者观点。
我们通过展示面向提供者的 SDM 工具来引出患者的观点。与 23 名高危肺癌患者进行了时长为 1.5 至 2 小时不等的焦点小组访谈。使用主题分析对数据进行归纳解释,以确定患者对面向患者的 SDM 工具的想法和期望。
研究结果强调,患者希望获得与肺癌筛查相关的教育信息。我们确定了几个需要考虑的关键主题,以便未来开发面向患者的工具:接受障碍、反对筛查和寻求赋权。另一个主题说明了医患关系作为满足肺癌筛查信息需求的局限性的影响。参与者还对技术决策辅助工具的设计提出了一些建议。
这些发现表明,患者在就诊前希望获得更多关于肺癌筛查的信息。然而,在设计和开发技术以满足患者对肺癌筛查决策的信息需求时,必须考虑几个问题。
患者、服务使用者、护理人员或公众未参与研究设计、进行、分析或解释数据。然而,健康传播方面的临床专家为研究方案,包括焦点小组方法,提供了详细的反馈。这些研究结果有助于更好地了解患者对肺癌筛查决策的期望,并可能为未来 SDM 工具的开发提供信息。